CSF3

colony stimulating factor 3, the group of Receptor ligands

Basic information

Region (hg38): 17:40015360-40017813

Previous symbols: [ "GCSF", "G-CSF", "C17orf33" ]

Links

ENSG00000108342NCBI:1440OMIM:138970HGNC:2438Uniprot:P09919AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CSF3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CSF3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
missense
8
clinvar
2
clinvar
10
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 8 0 5

Variants in CSF3

This is a list of pathogenic ClinVar variants found in the CSF3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-40015488-C-T not specified Uncertain significance (Nov 14, 2023)3078001
17-40015500-C-T not specified Uncertain significance (Jun 10, 2024)3269757
17-40015714-A-G not specified Uncertain significance (Mar 27, 2023)2530042
17-40015720-C-T not specified Uncertain significance (Oct 10, 2023)3078003
17-40015818-C-T Benign (Jul 06, 2018)741620
17-40015825-G-A not specified Uncertain significance (Dec 06, 2022)2371631
17-40016314-A-G not specified Uncertain significance (Jun 29, 2022)2410207
17-40016509-A-G not specified Uncertain significance (Jun 07, 2023)2558350
17-40016519-T-G not specified Uncertain significance (Feb 27, 2024)3078002
17-40016578-T-G not specified Uncertain significance (Mar 29, 2022)2280151
17-40016787-C-G Benign (Jul 10, 2018)728891
17-40016804-C-A Benign (Dec 31, 2019)712649
17-40016848-G-T Benign (Aug 20, 2018)768877
17-40016854-C-T Benign (Jul 07, 2018)712650
17-40016855-G-A Benign (Dec 31, 2019)720537

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CSF3protein_codingprotein_codingENST00000225474 52453
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.3800.610125696041257000.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.976871170.7460.000006671311
Missense in Polyphen2539.2280.6373488
Synonymous-0.01445554.91.000.00000351439
Loss of Function2.1829.110.2203.91e-799

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005810.0000581
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001780.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Granulocyte/macrophage colony-stimulating factors are cytokines that act in hematopoiesis by controlling the production, differentiation, and function of 2 related white cell populations of the blood, the granulocytes and the monocytes-macrophages. This CSF induces granulocytes.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);Jak-STAT signaling pathway - Homo sapiens (human);Malaria - Homo sapiens (human);IL-17 signaling pathway - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);JAK-STAT-Core;Hematopoietic Stem Cell Differentiation;Lung fibrosis;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Interleukin-10 signaling;PI3K-Akt Signaling Pathway;Cytokines and Inflammatory Response;Other interleukin signaling;Signaling by Interleukins;Cytokine Signaling in Immune system;JAK STAT MolecularVariation 1;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Immune System;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;JAK STAT pathway and regulation;GPCR signaling-G alpha i (Consensus)

Recessive Scores

pRec
0.850

Intolerance Scores

loftool
0.643
rvis_EVS
0.22
rvis_percentile_EVS
68.13

Haploinsufficiency Scores

pHI
0.799
hipred
N
hipred_score
0.203
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.817

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Csf3
Phenotype
hematopoietic system phenotype; renal/urinary system phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
csf3b
Affected structure
blood island
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
immune response;multicellular organism development;positive regulation of cell population proliferation;regulation of signaling receptor activity;positive regulation of phosphatidylinositol 3-kinase signaling;cytokine-mediated signaling pathway;positive regulation of actin filament polymerization;granulocyte differentiation;positive regulation of protein binding;positive regulation of peptidyl-serine phosphorylation;response to ethanol;positive regulation of myeloid cell differentiation;positive regulation of transcription by RNA polymerase II;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of DNA-binding transcription factor activity;positive regulation of protein kinase B signaling;cellular response to lipopolysaccharide;cellular response to cytokine stimulus;negative regulation of neuron death;positive regulation of actin cytoskeleton reorganization
Cellular component
extracellular region;extracellular space
Molecular function
cytokine activity;granulocyte colony-stimulating factor receptor binding;growth factor activity;enzyme binding